| |
 |
|
Class Information
Number: 514/199
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) > 6-position substituent contains carbocyclic ring > Penicillin g per se or salt thereof (e.g., procaine pencillin g, etc.)
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7365047 |
Use of pentagastrin to inhibit gastric acid secretion or as a diuretic |
Apr. 29, 2008 |
| 7244720 |
Soluble forms of amoxicillin and treatment of animals |
Jul. 17, 2007 |
| 7094431 |
Method of healing skin wounds in mammals and a composition therefor |
Aug. 22, 2006 |
| 6946477 |
3-Substituted piperidines comprising urea functionality, and methods of use thereof |
Sep. 20, 2005 |
| 6833389 |
Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful in the treatment of Chlamydia pneumoniae infections |
Dec. 21, 2004 |
| 6756369 |
Diagnosis and management of infection caused by Chlamydia |
Jun. 29, 2004 |
| 6743440 |
Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals |
Jun. 1, 2004 |
| 6664239 |
Diagnosis and management of infection caused by Chlamydia |
Dec. 16, 2003 |
| 6627625 |
Treatment of behavioral disorders with .beta.-lactam compounds |
Sep. 30, 2003 |
| 6599892 |
7-alkylidene cephalosporanic acid derivatives and methods of using the same |
Jul. 29, 2003 |
| 6537985 |
Antibiotic formulation and a method of making this formulation |
Mar. 25, 2003 |
| 6492354 |
Soluble forms of amoxicillin and treatment of animals |
Dec. 10, 2002 |
| 6461607 |
Probiotic, lactic acid-producing bacteria and uses thereof |
Oct. 8, 2002 |
| 6429191 |
Treatment of hearing impairments |
Aug. 6, 2002 |
| 6417174 |
Inhibitors of .beta.-lactamases and uses therefor |
Jul. 9, 2002 |
| 6316015 |
Hyperbactericidal surfaces |
Nov. 13, 2001 |
| 6303644 |
Proton pump inhibitor in therapeutic combination with antibacterial substances |
Oct. 16, 2001 |
| 6225282 |
Treatment of hearing impairments |
May. 1, 2001 |
| 6225304 |
Soluble forms of amoxicillin and treatment of animals |
May. 1, 2001 |
| 6221859 |
Carbapenem antibacterial compositions and methods of the treatment |
Apr. 24, 2001 |
| 6187768 |
Kit for flushing medical devices and method of preparation |
Feb. 13, 2001 |
| 6159706 |
Application of enzyme prodrugs as anti-infective agents |
Dec. 12, 2000 |
| 6143742 |
Treatment for necrotizing infections |
Nov. 7, 2000 |
| 6127355 |
High molecular weight polymer-based prodrugs |
Oct. 3, 2000 |
| 6093414 |
Silver-based antimicrobial compositions |
Jul. 25, 2000 |
| 6051604 |
Methods and compositions for the prevention and treatment of gastrointestinal disorders |
Apr. 18, 2000 |
| 5972309 |
Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment |
Oct. 26, 1999 |
| 5948422 |
Oral dosage-forms containing a .beta.-lactam antibiotic |
Sep. 7, 1999 |
| 5935603 |
Water soluble powder form compositions and their applications thereof |
Aug. 10, 1999 |
| 5883074 |
Potentiators of antibacterial agents |
Mar. 16, 1999 |
| 5827543 |
Methods and compositions for the prevention and treatment of urogenital disorders |
Oct. 27, 1998 |
| 5795563 |
Identification of an exogenous intra-erythrocytic bacterium in patients having systemic lupus erythematosus, and treatment |
Aug. 18, 1998 |
| 5780049 |
Enhanced skin penetration system for improved topical delivery of drugs |
Jul. 14, 1998 |
| 5770585 |
Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal |
Jun. 23, 1998 |
| 5744168 |
Methods and compositions for the prevention and treatment of gastrointestinal disorders |
Apr. 28, 1998 |
| 5712268 |
Compositions of tricyclic .beta.-lactams and uses thereof |
Jan. 27, 1998 |
| 5698533 |
Ophthalmic pharmaceutical composition |
Dec. 16, 1997 |
| 5698577 |
Compositions of bicyclic .beta.-lactams and uses thereof |
Dec. 16, 1997 |
| 5674858 |
Medicaments for treating gastrointestinal disorders |
Oct. 7, 1997 |
| 5643902 |
Veterinary treatment |
Jul. 1, 1997 |
| 5633245 |
Inhibition of expression of beta-lactamase using esters of fatty acid alcohols |
May. 27, 1997 |
| 5633244 |
Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
May. 27, 1997 |
| 5631298 |
Growth promotion |
May. 20, 1997 |
| 5629305 |
Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
May. 13, 1997 |
| 5618564 |
Composition for the treatment of helicobacter pylori infection |
Apr. 8, 1997 |
| 5484809 |
Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid |
Jan. 16, 1996 |
| 5478819 |
Phospholipid composition and use thereof |
Dec. 26, 1995 |
| 5476669 |
Method for treatment of gastro intestinal disorders |
Dec. 19, 1995 |
| 5466685 |
Inhibition of expression of beta-lactamase using esters of fatty acid alcohols |
Nov. 14, 1995 |
| 5466685 |
Inhibition of expression of beta-lactamase using esters of fatty acid alcohols |
Nov. 14, 1995 |
|
|
|
